In a prospective study by Mittal et al [13], conducted at a tertiary centre in North India in which consecutive carcinoma breast patients (n = 236) were subjected to multigene hereditary germline panel testing, P/LP variants were found in 44/236 (18.64%) women; variants in BRCA1 (22/47, 46.8%) and BRCA2 (9/47, 19.1%) were the most common, with 34% of variants present in non-BRCA genes. The gene discussed is BRCA2; the disease is carcinoma.